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Targeting the methionine salvage pathway as a metabolic point of leverage in novel 
therapeutic approaches for prostate cancer. 
 
Polyamines are essential metabolites required for cellular proliferation and a multitude of 
cellular processes. The prostate is unique in that high levels of acetylated polyamine secretion 
into the lumen causes increased biosynthetic flux to replenish intracellular polyamine pools. 
This increased flux strains metabolic pathways such as one-carbon metabolism and the 
methionine cycle as well as depleting nucleotide and s-adenosylmethionine pools. More 
importantly, this stress is increased in prostate cancer (PCa) due to increased polyamine 
acetylation, DNA synthesis and cellular proliferation. We hypothesized that the methionine 
salvage pathway, responsible for recycling one carbon units to the methionine cycle, is 
critical to PCa due to high metabolic flux through polyamine biosynthesis. We propose this 
dependence can be enhanced by targeting two different aspects of the aforementioned 
metabolic pathways with the use of pharmacologics. In cell line studies, we 
pharmacologically increased polyamine flux in PCa cells with the use of a polyamine 
analogue N (1),N (11)-bis(ethyl)norspermine (BENSpm). BENSpm is found to upregulate 
spermidine/spermine N(1)-acetyltransferase (SSAT), an enzyme necessary for polyamine 
acetylation. We found that this synergized with an inhibitor of the methionine salvage 
pathway, methylthio-DADMe-Immucillin-A (MTDIA). By adding stress to an already 
strained system and blocking pathways that mitigate this stress with the use of 
pharmacologics, we were able to see a decrease in PCa cellular proliferation in vitro. Further 
studies hope to look at their effects in vivo. 
 
